ArticlePulmonary circulation2025
Prognostic Value of the TAPSE/PASP Ratio in Lung Transplant Candidates With Advanced Interstitial Lung Disease.
Article in Pulmonary circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Value of the TAPSE/PASP Ratio in Lung Transplant Candidates With Advanced Interstitial Lung Disease.Pulmonary circulation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Right ventricular (RV) dysfunction is a critical yet often underrecognized determinant of prognosis in patients with advanced interstitial lung disease (ILD) undergoing lung transplant evaluation. The tricuspid annular plane systolic excursion to pulmonary arterial systolic pressure (TAPSE/PASP) ratio has emerged as a promising noninvasive echocardiographic surrogate of RV-pulmonary arterial (RV-PA) coupling, offering a dynamic estimate of RV function relative to afterload. In this single-center retrospective cohort study, we assessed the prognostic association of the TAPSE/PASP ratio in 65 lung transplant candidates with advanced ILD. All patients underwent comprehensive transthoracic echocardiography and right heart catheterization as part of pre-transplant evaluation. The primary endpoint was a composite of all-cause mortality or lung transplantation. Over a median follow-up of 24 months, 33 patients (50.8%) reached this endpoint. Receiver operating characteristic (ROC) curve analysis identified an optimal TAPSE/PASP cutoff value of 0.55 (AUC: 0.763,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.